MedTrace Logo

Development and Evaluation of an Artificial Intelligence Model for the Diagnosis of Aeroallergies

NCT05918354 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 993

Last updated 2024-10-16

No results posted yet for this study

Summary

To improve accuracy and take out human error, Hippo Dx previously developed S.P.A.T., an automated skin prick test. Now, Hippo Dx will develop and evaluate a S.P.A.T. artificial intelligence (AI) medical software to support physicians in the read out of the test results from an automated skin prick test.

In this study 700 images will be collected to develop the AI model, an additional 200 images will be collected to evaluate performance of the AI model. In a last independent cohort of 100 patients, performance of read-out by the physician will be compared with read out by the physician supported by the S.P.A.T. AI medical software.

The primary endpoint is the accuracy of the maximal wheal size measurement by S.P.A.T. AI versus the maximal wheal size measurement by the physician.

It is a prospective multicentric study that will include 1000 study participants from different countries.

Conditions

  • Allergy

Interventions

DEVICE

Skin Prick Automated Test

Detection of sensitisation to specific allergens via the skin prick automated test.

Sponsors & Collaborators

  • Hippocreates

    lead INDUSTRY

Principal Investigators

  • Mark Jorissen, MD, PhD · UZ Leuven

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-10
Primary Completion
2024-09-11
Completion
2024-09-11

Countries

  • Belgium
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05918354 on ClinicalTrials.gov